Acurx Pharmaceuticals Inc... (ACXP)

AI Score

Unlock

0.37

-0.02 (-3.92%)

At close: Apr 17, 2025, 3:59 PM

0.39

5.02%

After-hours: Apr 17, 2025, 04:54 PM EDT

Acurx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M	-4M	-1.47M	-1.09M	-1.31M	-913.36K	-1.28M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	538.37K	317.56K	1.02M	1.2M	1.23M	833.28K	806.49K	899.38K	696.97K	824.04K	716.68K	949.17K	760.14K	3.4M	2.26M	327.14K	285.77K	306.64K	327.76K	347.77K
Other Working Capital	-53.22K	-125.88K	-31.63K	-14.33K	-310.15K	188.19K	1.06M	-12.3M	-265.32K	537.5K	283.23K	210.73M	-21.23K	-186.03K	1.48M	-304.96K	-40.52K	5.28K	-608	35.34K
Other Non-Cash Items	n/a	440.1K	256.18K	1.07M	393.68K	833.28K	806.49K	899.38K	812.47K	824.04K	716.68K	949.17K	760.14K	46.07K	-66.5K	916.76K	-111.98K	375.51K	13.55K	781.7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-6.98K	-125.88K	-31.63K	114.83K	-310.15K	188.19K	1.06M	70.65K	952.46K	537.5K	-86.8K	-155.03K	366.75K	-1.39M	1.48M	-316.71K	-152.5K	249.14K	-148.15K	-749.66K
Operating Cash Flow	-2.25M	-2.19M	-2.88M	-3.06M	-4.2M	-2.09M	-1.58M	-1.93M	-1.5M	-2.18M	-1.99M	-1.88M	-1.5M	-2.64M	-329.81K	-547.14K	-959.75K	-758.76K	-733.75K	-899.29K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	66.5K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	6.41B	n/a	210.2K	4.62M	n/a	73.00	n/a	-3.7M	3.7M	n/a	n/a	14.78B	n/a	n/a	n/a	n/a	n/a	1.06M	n/a
Financial Cash Flow	194.55K	6.42B	320.21K	4.51M	4.62M	n/a	3.54M	n/a	-1	3.7M	n/a	n/a	14.78B	n/a	14.8M	n/a	728.54K	2.19M	1.12M	n/a
Net Cash Flow	-2.06M	-598.29K	-2.56M	1.45M	421.86K	-2.09M	-8.76M	-1.93M	-1.5M	1.52M	-1.99M	-1.88M	-1.5M	-2.64M	14.47M	-547.14K	-231.22K	1.43M	390.41K	-899.29K
Free Cash Flow	-2.25M	-2.19M	-2.88M	-3.06M	-4.2M	-2.09M	-1.58M	-1.93M	-1.5M	-2.18M	-1.99M	-1.88M	-1.5M	-2.64M	-329.81K	-547.14K	-959.75K	-758.76K	-733.75K	-899.29K